Association of CETP, APOA5, IL6, and PON1 Gene Variants with Dyslipidemia and Cardiovascular Risk in a Population from Cauca Department, Colombia
Genes · 2025
DOI: 10.3390/genes16050545 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Genes, 2025. Verfasst von Astrid Lorena Urbano-Cano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Investigación en Salud Integral (GISI), Departamento Facultad de Salud, Universidad Santiago de Cali, Cali 760035, Colombia. Hauptthemen laut MEDLINE: Cholesterol Ester Transfer Proteins, Dyslipidemias, Apolipoprotein A-V, Aryldialkylphosphatase. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Direccion General de Investigaciones of Universidad Santiago de Cali.
Abstract (Originalsprache)
Background
Cardiovascular disease remains the leading cause of death worldwide, and dyslipidemia is a critical, modifiable risk factor.
Aim
We sought to evaluate the relationship between polymorphisms in CETP (rs3764261), APOA5 (rs662799), IL6 (rs1800796), and PON1 (Q192R) and lipid parameters, and to assess their contribution to dyslipidemia and overall cardiovascular risk in an urban cohort from Cauca, Colombia.
Methods
In this cross-sectional observational study, 304 participants aged 40–69 years were enrolled. Clinical, anthropometric, and biochemical data were collected, and genotyping was performed for the four target polymorphisms. We used descriptive statistics to characterize the sample, non-parametric tests to compare lipid levels by genotype, and multivariable logistic regression to identify independent predictors of dyslipidemia.
Results
Individuals with dyslipidemia exhibited significantly higher total cholesterol and VLDL levels, lower HDL levels, and an elevated Castelli II index compared with the non-dyslipidemia group. Although CETP genotype frequencies differed between groups, only the APOA5 rs662799 variant was significantly associated with increased VLDL levels, suggesting its potential role as a genetic biomarker of cardiovascular risk.
Conclusions
Our findings underscore the interplay between metabolic factors and genetic variants in the pathogenesis of dyslipidemia. Notably, the APOA5 rs662799 polymorphism emerged as a key determinant of VLDL concentration, highlighting its promise for personalized cardiovascular risk stratification and management in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grupo de Investigación en Salud Integral (GISI), Departamento Facultad de Salud, Universidad Santiago de Cali, Cali 760035, Colombia.
- Grupo de Investigación en Genética Humana Aplicada (GIGHA), Departamento de Ciencias Fisiológicas, Universidad del Cauca, Popayan 190003, Colombia.
ORCID-Profile: Astrid Lorena Urbano-Cano, Rosa Elvira Álvarez-Rosero, Yamil Liscano
Förderung
- Direccion General de Investigaciones of Universidad Santiago de Cali
Zitieren
APA
Urbano-Cano, A. L., Álvarez-Rosero, R. E., & Liscano, Y. (2025). Association of CETP, APOA5, IL6, and PON1 Gene Variants with Dyslipidemia and Cardiovascular Risk in a Population from Cauca Department, Colombia. Genes. https://doi.org/10.3390/genes16050545
Vancouver
Urbano-Cano AL, Álvarez-Rosero RE, Liscano Y. Association of CETP, APOA5, IL6, and PON1 Gene Variants with Dyslipidemia and Cardiovascular Risk in a Population from Cauca Department, Colombia. Genes. 2025. doi:10.3390/genes16050545
BibTeX
@article{UrbanoCano2025,
author = {Urbano-Cano, Astrid Lorena and Álvarez-Rosero, Rosa Elvira and Liscano, Yamil},
title = {Association of CETP, APOA5, IL6, and PON1 Gene Variants with Dyslipidemia and Cardiovascular Risk in a Population from Cauca Department, Colombia},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16050545}
}
EUVIMED